These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11422779)

  • 1. Nitric oxide and the liver.
    Farzaneh-Far R; Moore K
    Liver; 2001 Jun; 21(3):161-74. PubMed ID: 11422779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins.
    Battista S; Bar F; Mengozzi G; Zanon E; Grosso M; Molino G
    J Hepatol; 1997 Jan; 26(1):75-80. PubMed ID: 9148026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination?
    Rasaratnam B; Connelly N; Chin-Dusting J
    Clin Sci (Lond); 2004 Nov; 107(5):425-34. PubMed ID: 15270715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.
    Wiest R; Groszmann RJ
    Hepatology; 2002 Feb; 35(2):478-91. PubMed ID: 11826425
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications.
    Michielsen PP; Pelckmans PA
    Acta Gastroenterol Belg; 1994; 57(2):194-205. PubMed ID: 8053307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of extrahepatic vasodilation in portal hypertension.
    Hennenberg M; Trebicka J; Sauerbruch T; Heller J
    Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl(4)-induced cirrhosis.
    Bhimani EK; Serracino-Inglott F; Sarela AI; Batten JJ; Mathie RT
    J Surg Res; 2003 Jul; 113(1):172-8. PubMed ID: 12943827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.
    Zafra C; Abraldes JG; Turnes J; Berzigotti A; Fernández M; Garca-Pagán JC; Rodés J; Bosch J
    Gastroenterology; 2004 Mar; 126(3):749-55. PubMed ID: 14988829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of nitric oxide in portal hypertensive systemic and portal vascular pathology.
    Hartleb M; Michielsen PP; Dziurkowska-Marek A
    Acta Gastroenterol Belg; 1997; 60(3):222-32. PubMed ID: 9396180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
    Arkenau HT; Stichtenoth DO; Frölich JC; Manns MP; Böker KH
    Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperdynamic circulation in cirrhosis: a role for nitric oxide?
    Vallance P; Moncada S
    Lancet; 1991 Mar; 337(8744):776-8. PubMed ID: 1706450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
    Scher RL
    Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis.
    Sánchez-Rodríguez A; Criado M; Rodríguez-López AM; Esteller A; Martín de Arriba A; López-Novoa JM
    Clin Sci (Lond); 1998 Jun; 94(6):637-43. PubMed ID: 9854462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of intrahepatic microcirculation in cirrhotic livers.
    Yang YY; Lin HC
    J Chin Med Assoc; 2015 Aug; 78(8):430-7. PubMed ID: 26074366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nitric oxide and hyperdynamic circulation in liver cirrhosis].
    Wang Y; Gu C
    Zhonghua Nei Ke Za Zhi; 1995 Nov; 34(11):779-81. PubMed ID: 8731852
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
    Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
    World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.